Mirabegron
Who holds supplier records for Mirabegron? 39 organisations hold a current record for Mirabegron: an active US FDA Type II Drug Master File or a CEP. 20 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (28), China (6), Italy (1), Spain (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Mirabegron: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mirabegron
Reading the evidence
- 39 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
28 of the 38 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 20 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Mirabegron expires 30 Sept 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (39)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Mirabegron. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 30413, 28392, 29064 · latest filing Jun 2016
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 36682, 28071 · latest filing Jan 2022
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 30065 · latest filing Jan 2016
- AMI LIFESCIENCES PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 40421 · latest filing Oct 2024
- AMOLI ORGANICS PRIVATE LTDIndiaCEPActive DMF 38825 · latest filing Sept 2023
- Biocon LimitedIndiaCEPActive DMF 35117 · latest filing Sept 2020
- Jiangxi Synergy Pharmaceutical Co., LtdChinaCEPActive DMF 31661 · latest filing Apr 2017
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 29734 · latest filing Sept 2015
- Neuland Laboratories LimitedIndiaCEPActive DMF 38770 · latest filing Aug 2023
- Piramal Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 33281 · latest filing Oct 2018
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 30169 · latest filing Jan 2016
- SYNTHIMED LABS PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 41390 · latest filing Apr 2025
- Viwit Pharmaceutical Co., Ltd.ChinaCEPActive DMF 35980 · latest filing Sept 2021
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 30030 · latest filing Nov 2015
- Zhejiang Huayi Pharmaceutical Co., Ltd.ChinaCEPActive DMF 37800 · latest filing Dec 2022
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 30105 · latest filing Jan 2016
- AARTI PHARMALABS LIMITEDIndiaActive DMF 42590 · latest filing Oct 2025
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 30086 · latest filing Dec 2015
- CAMBREX PROFARMACO MILANO SRLItaly Company GMP cert on recordActive DMF 43688 · latest filing Feb 2026
- CHEMO SMS ENTERPRISE SLSpainActive DMF 38612 · latest filing Aug 2023
- Cipla LimitedIndia Company GMP cert on recordActive DMF 36778 · latest filing Mar 2022
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 33821 · latest filing Apr 2019
- DELMAR CHEMICALS INCCanadaActive DMF 32929 · latest filing Sept 2018
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 30291 · latest filing Feb 2016
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChina Company GMP cert on recordActive DMF 38156 · latest filing Mar 2023
- JUBILANT BIOSYS LTDIndiaActive DMF 33516 · latest filing Jul 2019
- LUPIN MANUFACTURING SOLUTIONS LTDActive DMF 29925 · latest filing Dec 2015
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 39526 · latest filing Apr 2024
- MEGAFINE PHARMA P LTDIndiaActive DMF 29773 · latest filing Sept 2015
- MEHTA API Pvt. Ltd.India Company GMP cert on recordActive DMF 40402 · latest filing Oct 2024
- METROCHEM API PRIVATE LTDIndiaActive DMF 36973 · latest filing Apr 2022
- RAKSHIT DRUGS PVT LTDIndiaActive DMF 42100 · latest filing Jul 2025
- SWATI SPENTOSE PRIVATE LTDIndiaActive DMF 43754 · latest filing Mar 2026
- SynthonNetherlands Company GMP cert on recordActive DMF 32440 · latest filing Feb 2018
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 33503 · latest filing Mar 2019
- IndiaCEP
- IndiaCEP
- ChinaCEP
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (20)
Certificates of Suitability on the EDQM register for Mirabegron, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 22 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2023-314 - Rev 01 Mirabegron | Nov 2026 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2024-378 - Rev 01 Mirabegron | Sept 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2024-056 - Rev 01 Mirabegron | May 2026 | — |
| SYNTHIMED LABS PRIVATE LIMITED Derabassi | IN | CEP 2025-017 - Rev 00 Mirabegron | May 2026 | Inspected Aug 2026 Slovenia |
| VIWIT PHARMACEUTICAL CO. LTD Tengzhou | CN | CEP 2024-039 - Rev 00 Mirabegron | Jan 2026 | — |
| MEGAFINE PHARMA PRIVATE LIMITED Mumbai | IN | CEP 2024-087 - Rev 02 Mirabegron | Nov 2025 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2024-015 - Rev 00 Mirabegron | Nov 2025 | — |
| PIRAMAL PHARMA LIMITED Digwal Village | IN | CEP 2024-093 - Rev 00 Mirabegron, Alpha form | Sept 2025 | Inspected Jun 2025 Netherlands |
| BIOCON LIMITED Bengaluru | IN | CEP 2023-460 - Rev 00 Mirabegron | Aug 2025 | — |
| LEWENS LABS PRIVATE LIMITED Dahej | IN | CEP 2024-344 - Rev 00 Mirabegron | Jul 2025 | — |
| VASUDHA PHARMA CHEM LIMITED Hyderabad | IN | CEP 2024-198 - Rev 00 Mirabegron | Jul 2025 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | CEP 2024-031 - Rev 00 Mirabegron, α-Form | Jul 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2024-033 - Rev 00 Mirabegron, Form-α | Jun 2025 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2024-208 - Rev 00 Mirabegron, alpha form | Jun 2025 | — |
| SHANDONG LONCOM PHARMACEUTICAL CO., LTD Dezhou | CN | CEP 2023-286 - Rev 00 Mirabegron | Jun 2025 | — |
| ZHEJIANG HUAYI PHARMACEUTICAL CO., LTD. Jinhua | CN | CEP 2024-037 - Rev 00 Mirabegron | May 2025 | — |
| AMI LIFESCIENCES PRIVATE LIMITED Vadodara | IN | CEP 2024-105 - Rev 00 Mirabegron | May 2025 | Inspected Oct 2025 Slovakia |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2023-308 - Rev 00 Mirabegron | Apr 2025 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2023-249 - Rev 00 Mirabegron, Micronised and non-micronised | Apr 2025 | Inspected May 2026 Italy |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun | CN | CEP 2023-180 - Rev 02 Mirabegron | Oct 2024 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (18 listed products contain Mirabegron). The latest listed patent expires 30 Sept 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Mirabegron is a beta-3 adrenergic agonist used for the treatment of overactive bladder. It works by relaxing the detrusor muscle in the bladder, increasing its storage capacity.
Chemical identity
- IUPAC name
- 2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide
- Canonical SMILES
- C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
- InChIKey
- PBAPPPCECJKMCM-IBGZPJMESA-N
- Synonyms
- Myrbetriq API, betanis, betmiga, myrbetriq, ym-178, ym178
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- beta3-Adrenergic Agonist
- Mechanism of action
- Adrenergic beta3-Agonists; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A Inhibitors; P-Glycoprotein Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Mirabegron?
39 organisations hold an active US FDA Type II Drug Master File or a CEP for Mirabegron: Dr. Reddy's Laboratories Ltd. (India), MSN Laboratories Private Limited (India), ALIVUS LIFE SCIENCES LTD (India), AMI LIFESCIENCES PRIVATE LTD (India), AMOLI ORGANICS PRIVATE LTD (India), Biocon Limited (India), Jiangxi Synergy Pharmaceutical Co., Ltd (China) and MICRO LABS LTD (India), and 31 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Mirabegron Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 30413, 28392), MSN Laboratories Private Limited (DMF 36682, 28071), ALIVUS LIFE SCIENCES LTD (DMF 30065), AMI LIFESCIENCES PRIVATE LTD (DMF 40421), AMOLI ORGANICS PRIVATE LTD (DMF 38825), Biocon Limited (DMF 35117), Jiangxi Synergy Pharmaceutical Co., Ltd (DMF 31661) and MICRO LABS LTD (DMF 29734) and 27 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Mirabegron have a European Certificate of Suitability?
Yes. 20 organisations hold a valid CEP for Mirabegron on the EDQM register, including NEULAND LABORATORIES LIMITED Hyderabad (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), SYNTHIMED LABS PRIVATE LIMITED Derabassi (IN), VIWIT PHARMACEUTICAL CO. LTD Tengzhou (CN) and MEGAFINE PHARMA PRIVATE LIMITED Mumbai (IN) and 14 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Mirabegron?
Yes. The latest patent listed for an approved US product containing Mirabegron expires 30 Sept 2036, across 18 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Mirabegron supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Mirabegron?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.